PLEXI-T Trademark

Trademark Overview

On Monday, August 19, 2024, a trademark application was filed for PLEXI-T with the United States Patent and Trademark Office. The USPTO has given the PLEXI-T trademark a serial number of 98705565. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, August 19, 2024. This trademark is owned by TScan Therapeutics, Inc.. The PLEXI-T trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer

Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer
plexi-t

General Information

Serial Number98705565
Word MarkPLEXI-T
Filing DateMonday, August 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer
Goods and ServicesPharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTScan Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Monday, August 19, 2024NEW APPLICATION ENTERED

Related Keywords

plexi cancer treatment cell therapy pharmaceutical namely research cells development scientific